مقالات بر حسب مجله
»» مجلات » Hepatitis Monthly « دوره 4، شماره 7
- Optimal Therapy for Hepatitis C
Alavian SM - Acute Hepatitis C Infection
Lankarani KB - Hepatitis C Infection with Persistently Normal ALT levels
Tavakoli H, Adibi P - Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian
Alavian SM, Hajarizadeh B, Hajibeigi B, Doroudi T, Abar K - Peginterferon alfa-2a and Ribavirin in Patients with Chronic Hepatitis C and Inherited Bleeding Disorders
Merat S, Sohrabpour AA, Khaleghi S, Sohrabi MR, Rad KS, Radmard AR, Malekzadeh R - The Efficacy and Safety of Peginterferon Alpha-2a (PEGASYS) monotherapy in the Treatment of Chronic Hepatitis C Infected Subjects with Transfusion Dependent Thalassemia
Mirmomen S, Daryani NE, Malekzadeh R, Zali MR, Haghpanah B, Poursamimi P, Hashemi S, Alavian SM - The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial
Daryani NE, Haghpanah B, Sayyah AR, Hashtroudi AA, Bashashati M, Poursamimi P, Nikbin M - Peginterferon Alfa-2a (Pegasys) and Ribavirin in the Treatment of Chronic Hepatitis C
Zali MR, Shalmani HM, Norouzinia M, MohammadAlizadeh A, Nowroozi A, Behrouz N - Hearing Loss as a Complication of Peginterferon Alfa 2a Combination Therapy in a Patient with Hepatitis C Virus Infection
Toosi MN, Hassanabadi MS